Yes68%
Vol$6.09K
Markets5
Event Group
EventPOLYMARKET

Single EventPOLYMARKETFinance
Will Johnson & Johnson (JNJ) Q3 Innovative Medicine revenue be above __?
Part of: Will Johnson & Johnson (JNJ) Q3 Innovative Medicine revenue be above __?This market will resolve to "Yes" if Johnson & Johnson's Innovative Medicine revenue for the upcoming third fiscal quarter, as reported in its official company earnings materials, is above the listed amount. Otherwise, this market will resolve to "No". The specified metric will be considered as reported in the company's official earnings materials. Subsequent revisions will not be considered. If the specified company's official earnings materials for the specified quarter are released, and the
YesLeading Yes Probability
68%
|
VolTotal Volume
$6.09K
|
Markets
5
Ends
Oct 13, 2026
in 1 dayWill Johnson & Johnson (JNJ) Q3 Innovative Medicine revenue be above __?

Yes
68%
|
Vol
$6.09K
|
Markets
5
Market Price Graph
5 markets tracked
Will Johnson & Johnson (JNJ) Q3 Innovative Medicine revenue be above $16.6B?
polymarket
No data available
All Markets(5)
| Market | Price |
|---|---|
Will Johnson & Johnson (JNJ) Q3 Innovative Medicine revenue be above $16.6B? | 68% |
Will Johnson & Johnson (JNJ) Q3 Innovative Medicine revenue be above $17B? | 46% |
Will Johnson & Johnson (JNJ) Q3 Innovative Medicine revenue be above $16.8B? | 40% |
Will Johnson & Johnson (JNJ) Q3 Innovative Medicine revenue be above $17.2B? | 27% |
Will Johnson & Johnson (JNJ) Q3 Innovative Medicine revenue be above $17.4B? | 13% |
Markets (5)
Sort
